» Articles » PMID: 17388982

Juvenile-onset Neuronal Ceroid Lipofuscinosis with Infantile CLN1 Mutation and Palmitoyl-protein Thioesterase Deficiency

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2007 Mar 29
PMID 17388982
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Accurate diagnosis, especially in progressive hereditary diseases, is essential for the treatment and genetic counseling of the patient and the family. Neuronal ceroid lipofuscinoses (NCL) are amongst the most common groups of neurodegenerative diseases. Infantile, juvenile, and adult-onset types with multiple genotype-phenotype associations have been described. A fluorimetric enzyme assay for palmitoyl protein thioesterase (PPT) from leukocytes and fibroblasts has been previously developed to confirm the diagnosis of infantile NCL. We describe a patient with juvenile-onset NCL phenotype with a new CLN1 mutation and deficient PPT activity. Over 40 different mutations have been found in patients with PPT deficiency, indicating that screening for known mutations is not an efficient way to diagnose this disorder. Therefore, PPT enzyme analysis should precede mutation analysis in suspected PPT deficiency, particularly in patients with granular osmiophilic deposits (GROD) or in patients who have negative ultrastructural data. The use of enzyme assay led to the diagnosis of this patient with juvenile-onset Finnish variant NCL with PPT deficiency, and we expect that greater awareness of the utility of the enzymatic assay may lead to identification of other similar cases awaiting a definitive diagnosis.

Citing Articles

Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a complex retinal phenotype.

Atiskova Y, Bartsch S, Danyukova T, Becker E, Hagel C, Storch S Sci Rep. 2019; 9(1):14185.

PMID: 31578378 PMC: 6775149. DOI: 10.1038/s41598-019-50726-8.


Using the social amoeba Dictyostelium to study the functions of proteins linked to neuronal ceroid lipofuscinosis.

Huber R J Biomed Sci. 2016; 23(1):83.

PMID: 27881166 PMC: 5122030. DOI: 10.1186/s12929-016-0301-0.


NCL diseases - clinical perspectives.

Schulz A, Kohlschutter A, Mink J, Simonati A, Williams R Biochim Biophys Acta. 2013; 1832(11):1801-6.

PMID: 23602993 PMC: 4631127. DOI: 10.1016/j.bbadis.2013.04.008.


Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients.

Perez-Poyato M, Mila Recansens M, Abizanda I, Montero Sanchez R, Rodriguez-Revenga L, Sanchez V J Inherit Metab Dis. 2011; 34(5):1083-93.

PMID: 21499717 DOI: 10.1007/s10545-011-9323-7.


Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Kohan R, Cismondi I, Oller-Ramirez A, Guelbert N, Anzolini T, Alonso G Curr Pharm Biotechnol. 2011; 12(6):867-83.

PMID: 21235444 PMC: 3632406. DOI: 10.2174/138920111795542633.